
浏览全部资源
扫码关注微信
达州市中西医结合医院胸外科,四川 达州 635000
吴博,E-mail:wbkevin111@163.com
收稿:2025-09-05,
纸质出版:2026-05-25
移动端阅览
吴博,胡健,汤兴松等.多点位胸腔引流联合尿激酶注射治疗复杂性胸腔积液的疗效观察[J].局解手术学杂志,2026,35(05):445-448.
WU Bo,HU Jian,TANG Xing-song,et al.Efficacy of multiple-point thoracic drainage combined with urokinase injection in the treatment of complicated pleural effusion[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2026,35(05):445-448.
吴博,胡健,汤兴松等.多点位胸腔引流联合尿激酶注射治疗复杂性胸腔积液的疗效观察[J].局解手术学杂志,2026,35(05):445-448. DOI: 10.11659/jjssx.09E025017.
WU Bo,HU Jian,TANG Xing-song,et al.Efficacy of multiple-point thoracic drainage combined with urokinase injection in the treatment of complicated pleural effusion[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2026,35(05):445-448. DOI: 10.11659/jjssx.09E025017.
目的
2
探讨多点位胸腔引流并胸腔内注入尿激酶治疗复杂性胸腔积液的疗效。
方法
2
选取我院2024年3-12月收治的135例复杂性胸腔积液患者,按照引流方法不同分为多点位引流组、单点位引流+尿激酶组、多点位引流+尿激酶组,每组45例。多点位引流组患者采用多点位胸腔引流,单点位引流+尿激酶组患者采用单点位胸腔引流并胸腔内注入尿激酶,多点位引流+尿激酶组患者采用多点位胸腔引流加胸腔内注入尿激酶。比较各组患者胸腔积液吸收时间、气促缓解时间、住院时间、炎症指标及出院后2个月胸膜厚度。
结果
2
各组患者胸腔积液吸收时间、气促缓解时间及住院时间对比差异有统计学意义(
P
0.05),其中多点位引流+尿激酶组患者胸腔积液吸收时间、气促缓解时间及住院时间短于多点位引流组和单点位引流+尿激酶组(
P
0.05)。各组患者治疗后红细胞沉降率、C反应蛋白水平对比差异有统计学意义(
P
0.05),其中多点位引流+尿激酶组患者治疗后上述炎症指标水平低于多点位引流组和单点位引流+尿激酶组(
P
0.05)。各组患者出院后2个月胸膜厚度对比差异有统计学意义(
P
0.05),其中多点位引流+尿激酶组患者出院后2个月胸膜厚度小于多点位引流组和单点位引流+尿激酶组(
P
0.05)。
结论
2
多点位胸腔引流联合尿激酶注射的方案在复杂性胸腔积液的治疗中能够加快胸腔积液的吸收和引流,显著改善胸膜厚度及炎症水平,为胸膜病变的治疗提供了新的思路和方法。
Objective
2
To investigate the efficacy of multiple-point thoracic drainage combined with intrapleural injection of urokinase in the treatment of complicated pleural effusion.
Methods
2
A total of 135 patients with complicated pleural effusion admitted to our hospital from March to December 2024 were selected and divided into the multiple-point drainage group, single-point drainage+urokinase group, and multiple-point drainage+urokinase group based on drainage methods,with 45 cases in each group. Patients in the multiple-point drainage group received multiple-point thoracic drainage alone; those in the single-point drainage+urokinase group received single-point thoracic drainage combined with intrapleural injection of urokinase; and those in the multiple-point drainage+urokinase group received multiple-point thoracic drainage plus intrapleural injection of urokinase. The pleural effusion absorption time, time to relief of shortness of breath, hospital stay,inflammatory indicators,and pleural thickness 2 months after discharge were compared in each group.
Results
2
Statistically significant differences were found in the pleural effusion absorption time, time to relief of shortness of breath,and hospital stay among groups (
P
0.05); among them, the multiple-point drainage+urokinase group exhibited shorter pleural effusion absorption time,time to relief of shortness of breath,and hospital stay compared to the multiple-point drainage group and the single-point drainage+urokinase group (
P
0.05). There were statistically significant differences in the erythrocyte sedimentation rate and level of C-reactive protein after treatment among groups (
P
0.05); among them,the multiple-point drainage+urokinase group showed lower levels of these inflammatory indicators after treatment compared to the multiple-point drainage group and the single-point drainage+urokinase group (
P
0.05). There was a statistically significant difference in pleural thickness 2 months after discharge among groups (
P
0.05); among them, the multiple-point drainage+urokinase group had reduced pleural thickness 2 months after discharge compared to the multiple-point drainage group and the single-point drainage+urokinase group (
P
0.05).
Conclusion
2
The regimen of multiple-point pleural drainage combined with urokinase injection can accelerate the absorption and drainage of pleural effusion in the treatment of complicated pleural effusion. It can also significantly reduce the pleural thickness and alleviate inflammation,providing a new approach and method for the treatment of pleural lesions.
Botana Rial M , Pérez Pallarés J , Cases Viedma E , et al . Diagnosis and treatment of pleural effusion. Recommendations of the Spanish Society of Pulmonology and Thoracic Surgery. Update 2022 [J]. Arch Bronconeumol , 2023 , 59 ( 1 ): 27 - 35 . doi: 10.1016/j.arbres.2022.09.017 http://dx.doi.org/10.1016/j.arbres.2022.09.017 .
Pardessus Otero A , Rafecas-Codern A , Porcel JM , et al . Malignant pleural effusion: a multidisciplinary approach [J]. Open Respir Arch , 2024 , 6 ( 4 ): 100349 . doi: 10.1016/j.opresp.2024.100349 http://dx.doi.org/10.1016/j.opresp.2024.100349 .
Kadhem H , Sridharan K , Naser N . Intrapleural tenecteplase for complicated parapneumonic pleural effusion [J]. Case Rep Pulmonol , 2021 , 2021 : 2206692 . doi: 10.1155/2021/2206692 http://dx.doi.org/10.1155/2021/2206692 .
于明子 , 梁志欣 . 复杂性胸腔积液和脓胸诊治新进展 [J]. 中华医院感染学杂志 , 2020 , 30 ( 17 ): 2712 - 2720 . doi: 10.11816/cn.ni.2020-192509 http://dx.doi.org/10.11816/cn.ni.2020-192509 .
姚冉 , 吴开怀 . 胸腔内注射尿激酶联合中心静脉导管引流治疗结核性胸腔积液的效果观察 [J]. 现代实用医学 , 2021 , 33 ( 1 ): 119 - 121 . doi: 10.3969/j.issn.1671-0800.2021.01.061 http://dx.doi.org/10.3969/j.issn.1671-0800.2021.01.061 .
黄华 , 张中 , 姜欣 , 等 . 中心静脉导管引流联合尿激酶胸腔注入治疗结核性包裹性胸腔积液的效果分析 [J]. 中国医学创新 , 2020 , 17 ( 26 ): 1 - 4 . doi: 10.3969/j.issn.1674-4985.2020.26.001 http://dx.doi.org/10.3969/j.issn.1674-4985.2020.26.001 .
Abdul Hamid MF , Hasbullah AHH , Mohamad Jailaini MF , et al . Retrospective review comparing intrapleural fibrinolytic therapy (alteplase) and surgical intervention in complex pleural effusion [J]. BMC Pulm Med , 2022 , 22 ( 1 ): 439 . doi: 10.1186/s12890-022-02239-w http://dx.doi.org/10.1186/s12890-022-02239-w .
Smith D , Shaw H , Ryder T . Intrapleural tissue plasminogen activator and deoxyribonuclease administered concurrently and once daily for complex parapneumonic pleural effusion and empyema [J]. Intern Med J , 2023 , 53 ( 12 ): 2313 - 2318 . doi: 10.1111/imj.16084 http://dx.doi.org/10.1111/imj.16084 .
Changchien CY , Chen Y , Chang HH , et al . Effect of malignant-associated pleural effusion on endothelial viability,motility and angiogenesis in lung cancer [J]. Cancer Sci , 2020 , 111 ( 10 ): 3747 - 3758 . doi: 10.1111/cas.14584 http://dx.doi.org/10.1111/cas.14584 .
Zayed NE , El Fakharany K , Mehriz Naguib Abozaid M . Intrapleural instillation of sodium bicarbonate versus urokinase in management of complicated pleural effusion: a comparative cohort study [J]. Int J Gen Med , 2022 , 15 : 8705 - 8713 . doi: 10.2147/IJGM.S388488 http://dx.doi.org/10.2147/IJGM.S388488 .
Sorino C , Mondoni M , Lococo F , et al . Optimizing the management of complicated pleural effusion: from intrapleural agents to surgery [J]. Respir Med , 2022 , 191 : 106706 . doi: 10.1016/j.rmed.2021.106706 http://dx.doi.org/10.1016/j.rmed.2021.106706 .
Tucker TA , Idell S . The contribution of the urokinase plasminogen activator and the urokinase receptor to pleural and parenchymal lung injury and repair: a narrative review [J]. Int J Mol Sci , 2021 , 22 ( 3 ): 1437 . doi: 10.3390/ijms22031437 http://dx.doi.org/10.3390/ijms22031437 .
Bates D , Yang N , Bailey M , et al . Prevalence,characteristics,drainage and outcome of radiologically diagnosed pleural effusions in critically ill patients [J]. Crit Care Resusc , 2020 , 22 ( 1 ): 45 - 52 . doi: 10.51893/2020.1.oa5 http://dx.doi.org/10.51893/2020.1.oa5 .
Luque Paz D , Bayeh B , Chauvin P , et al . Intrapleural use of urokinase and DNase in pleural infections managed with repeated thoracentesis: a comparative cohort study [J]. PLoS One , 2021 , 16 ( 9 ): e0257339 . doi: 10.1371/journal.pone.0257339 http://dx.doi.org/10.1371/journal.pone.0257339 .
Jing W , Weng R , Lin P , et al . Urokinase in the treatment of tuberculous pleurisy: a systematic review and meta-analysis [J]. BMC Infect Dis , 2024 , 24 ( 1 ): 258 . doi: 10.1186/s12879-024-08975-0 http://dx.doi.org/10.1186/s12879-024-08975-0 .
Ugajin M , Yanoma S , Kani H . Intrapleural urokinase injection after medical thoracoscopy for empyema and complicated para-pneumonic effusion: a case series [J]. Intern Med , 2023 , 62 ( 4 ): 571 - 576 . doi: 10.2169/internalmedicine.0060-22 http://dx.doi.org/10.2169/internalmedicine.0060-22 .
Zielinska-Krawczyk M , Stecka AM , Grabczak EM , et al . Impact of therapeutic thoracentesis and pleural pressure changes on breathing pattern,dyspnea,lung function,and arterial blood gases [J]. Pol Arch Intern Med , 2022 , 132 ( 4 ): 16185 . doi: 10.20452/pamw.16185 http://dx.doi.org/10.20452/pamw.16185 .
Cho Y , Lee HN , Shin JH , et al . Double-pigtail drainage catheter: a new design for efficient pleural drainage [J]. Medicina (Kaunas) , 2023 , 59 ( 6 ): 1089 . doi: 10.3390/medicina59061089 http://dx.doi.org/10.3390/medicina59061089 .
0
浏览量
4
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621